Vikalin tablets

Instructions for use of Vikalin tablets

Registration number: LS-001102

Proprietary name of the drug: Vikalin

International nonproprietary name: None

Chemical name: None

Dosage form: tablets

Composition:

Description:

Round, flat-cylindrical tablets of light brown color with noticeable specks, with a bevel and a score line.

Pharmacotherapeutic group: Intestinal antiseptic and astringent agent

ATC code: A02BX

Pharmacological properties:

A combined drug that has astringent, antacid, antispasmodic, and mild laxative effects. Magnesium carbonate and sodium bicarbonate reduce gastric juice acidity and decrease pepsin activity. Bismuth subnitrate forms a protective film on the gastric mucosa, exerting anti-inflammatory, bactericidal, and reparative actions. The included calamus rhizomes and khellin have an antispasmodic effect, while buckthorn bark has a laxative effect.

Indications for use:

As part of combination therapy: gastric and duodenal ulcer disease, hyperacid gastritis.

Contraindications:

Hypersensitivity to the drug components, hypoacid gastritis, renal failure, chronic appendicitis, enterocolitis, children under 18 years of age, pregnancy, lactation.

Dosage and administration:

Orally, 1-2 tablets 3 times a day after meals with 1/4 glass of warm water (the tablets should be crushed or dissolved in the specified amount of water). The course of treatment is 1-2 months. A repeat course should be taken after consultation with a doctor.

Precautions:

The possibility of encephalopathy associated with the accumulation of bismuth in the central nervous system should be considered with long-term use of the drug in high doses.

Stool may turn dark green or black during drug administration.

Overdose symptoms, measures for assistance:

No overdose data available.

Side effects:

Allergic reactions, increased stool frequency.

Interaction with other medicinal products:

Concomitant use with tetracyclines reduces their absorption. When combined with other preparations containing bismuth, the blood bismuth level increases. No interactions with other medicinal products have been identified.

Use during pregnancy and breastfeeding:

The use of the drug during pregnancy and lactation is contraindicated.

Effect on ability to drive vehicles and operate machinery:

Use with caution when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Pharmaceutical form:

Tablets

10 tablets in a contour non-blister pack made of paper with polymer coating.

10 tablets in a contour blister pack made of polyvinyl chloride film and printed lacquered aluminum foil.

1, 2, 5, 10 contour blister packs, or 1, 2, 5 contour non-blister packs together with the instructions for use are placed in a cardboard carton.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C. Keep out of reach of children.

Shelf life:

5 years. Do not use after the expiration date printed on the packaging.

Prescription status:

Over-the-counter.

Name and address of the legal entity in whose name the registration certificate is issued / organization accepting claims:

JSC "AVVA RUS", Russia, 121614, Moscow, Krylatskie Kholmy st., 30, building 9.

Tel/Fax: +7 (495) 956-75-54.

avva.com.ru

Address of the production site:

JSC "AVVA RUS", Russia, 610044, Kirov region, Kirov, Luganskaya st., 53a.

Tel.: +7 (8332) 25-12-29; +7 (495) 956-75-54.